Evidence for species differences in the regulation of MMPs by all-trans retinoic acid in cytokine-stimulated chondrocytes

Biorheology

Volumn 45, Issue 3-4, 2008, Pages 415-432

  Kirchmeyer, M ^a   Deffaud, J ^a   Sebillaud, S ^a   Moulin, D ^a   Koufany, M ^a   Netter, P ^a   Bianchi, A ^a   Jouzeau, J Y ^a  

^a Biopôle de l Université de Lorraine   (France)

Author keywords

All trans retinoic acid; AP 1; Metalloproteases; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; MESSENGER RNA; NITRIC OXIDE; NITRITE; RETINOIC ACID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA;

ANIMAL CELL; ARTHRITIS; CARTILAGE CELL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; GENE CONTROL; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SPECIES DIFFERENCE;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL CULTURE TECHNIQUES; CHONDROCYTES; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SPECIES SPECIFICITY; TRANSCRIPTION FACTOR AP-1; TRETINOIN;

EID: 52449091373     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: 10.3233/BIR-2008-0486     Document Type: Conference Paper

References (96)

1. G. Allenby, M.T. Bocquel, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Lovey, P. Kastner, J.F. Grippo, P. Chambon et al., Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids, Proc. Natl. Acad. Sci. USA 90 (1993), 30-34.
2. L.M. Austenaa and A.C. Ross, Potentiation of interferon-gamma-stimulated nitric oxide production by retinoic acid in RAW 264.7 cells, J. Leukoc. Biol. 70 (2001), 121-129.
3. R.T. Ballock, A. Heydemann, L.M. Wakefield, K.C. Flanders, A.B. Roberts and M.B. Sporn, Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-beta, J. Cell. Physiol. 159 (1994), 340-346.
4. P.A. Becherel, L. Le Goff, S. Ktorza, O. Chosidow, C. Frances, F. Issaly, J.M. Mencia-Huerta, P. Debre, M.D. Mossalayi and M. Arock, CD23-mediated nitric oxide synthase pathway induction in human keratinocytes is inhibited by retinoic acid derivatives, J. Invest. Dermatol. 106 (1996), 1182-1186.
5. B.C. Beehler, Y.J. Hei, S. Chen, J.A. Lupisella, J. Ostrowski, J.E. Starrett, D. Tortolani, K.M. Tramposch and P.R. Reczek, Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis, J. Rheumatol. 30 (2003), 355-363.
6. P. Borden, D. Solymar, A. Sucharczuk, B. Lindman, P. Cannon and R.A. Heller, Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes, J. Biol. Chem. 271 (1996), 23577-23581.
7. K. Bordji, J.P. Grillasca, J.N. Gouze, J. Magdalou, H. Schohn, J.M. Keller, A. Bianchi, M. Dauca, P. Netter and B. Terlain, Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes, J. Biol. Chem. 275 (2000), 12243-12250.
8. S. Boyault, M.A. Simonin, A. Bianchi, E. Compe, B. Liagre, D. Mainard, P. Becuwe, M. Dauca, P. Netter, B. Terlain and K. Bordji, 15-Deoxy-delta12,14- PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways, FEBS Lett. 501 (2001), 24-30.
9. C.E. Brinckerhoff, J.W. Coffey and A.C. Sullivan, Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid, Science 221 (1983), 756-758.
10. C.E. Brinckerhoff and L.M. Matrisian, Matrix metalloproteinases: a tail of a frog that became a prince, Nat. Rev. Mol. Cell Biol. 3 (2002), 207-214.
11. K. Bry and U. Lappalainen, Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1beta in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice, Semin. Perinatol. 30 (2006), 121-128.
12. P.S. Burrage, J.T. Huntington, M.B. Sporn and C.E. Brinckerhoff, Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligand, Arthritis Rheum. 56 (2007), 892-904.
13. P.S. Burrage, K.S. Mix and C.E. Brinckerhoff, Matrix metalloproteinases: role in arthritis, Front. Biosci. 11 (2006), 529-543.
14. J.P. Carbone, R.C. Baldridge, T.R. Koszalka, A.M. Bongiovanni and R.L. Brent, Characterization of cytosolic glucocorticoid receptor of fetal rat epiphyseal chondrocytes, J. Steroid Biochem. 35 (1990), 495-505.
15. P. Chaturvedi, M. Pratta, K. Steplewski, J. Connor and S. Kumar, Functional characterization of an orphan nuclear receptor, Rev-ErbAalpha, in chondrocytes and its potential role in osteoarthritis, Arthritis Rheum. 54 (2006), 3513-3522.
16. C.H. Chen, K.C. Lin, D.T. Yu, C. Yang, F. Huang, H.A. Chen, T.H. Liang, H.T. Liao, C.Y. Tsai, J.C. Wei and C.T. Chou, Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity, Rheumatology (Oxford) 45 (2006), 414-420.
17. J.Y. Chen, S. Penco, J. Ostrowski, P. Balaguer, M. Pons, J.E. Starrett, P. Reczek, P. Chambon and H. Gronemeyer, RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation, EMBO J. 14 (1995), 1187-1197.
18. M. Chivot, Retinoid therapy for acne. A comparative review, Am. J. Clin. Dermatol. 6 (2005), 13-19.
19. P.K. Datta and E.A. Lianos, Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells, Kidney Int. 56 (1999), 486-493.
20. P.K. Datta, R.S. Reddy and E.A. Lianos, Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis, Inflammation 25 (2001), 351-359.
21. R.M. Day, Y.H. Lee, A.M. Park and Y.J. Suzuki, Retinoic acid inhibits airway smooth muscle cell migration, Am. J. Respir. Cell Mol. Biol. 34 (2006), 695-703.
22. J.M. Dayer and B. Bresnihan, Targeting interleukin-1 in the treatment of rheumatoid arthritis, Arthritis Rheum. 46 (2002), 574-578.
23. Y. Devaux, S. Grosjean, C. Seguin, C. David, B. Dousset, F. Zannad, C. Meistelman, N. De Talance, P.M. Mertes and D. Ungureanu-Longrois, Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo, Am. J. Physiol. Endocrinol. Metab. 279 (2000), E1045-E1053.
24. S.T. Dheen, Y. Jun, Z. Yan, S.S. Tay and E.A. Ling, Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia, Glia 50 (2005), 21-31.
25. J.A. DiBattista, J. Martel-Pelletier, L.O. Wosu, T. Sandor, T. Antakly and J.P. Pelletier, Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes, J. Clin. Endocrinol. Metab. 72 (1991), 316-326.
26. N. Dugas, M.D. Mossalayi, A. Calenda, A. Leotard, P. Becherel, F. Mentz, F. Ouaaz, M. Arock, P. Debre, J. Dornand and B. Dugas, Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells, Blood 88 (1996), 3528-3534.
27. C.H. Evans, S.C.Watkins and M. Stefanovic-Racic, Nitric oxide and cartilage metabolism, Methods Enzymol. 269 (1996), 75-88.
28. Z. Fan, H. Yang, B. Bau, S. Soder and T. Aigner, Role of mitogen-activated protein kinases and NFkappaB on IL-1beta-induced effects on collagen type II, MMP-1 and 13 mRNA expression in normal articular human chondrocytes, Rheumatol. Int. 26 (2006), 900-903.
29. A.R. Farina, M.P. Masciulli, A. Tacconelli, L. Cappabianca, G. De Santis, A. Gulino and A.R. Mackay, All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells, Cell Growth Differ. 13 (2002), 343-354.
30. J.C. Fernandes, J. Martel-Pelletier, V. Lascau-Coman, F. Moldovan, D. Jovanovic, J.P. Raynauld and J.P. Pelletier, Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study, J. Rheumatol. 25 (1998), 1585-1594.
31. M. Fiedorczyk, P.A. Klimiuk, S. Sierakowski, E. Gindzienska-Sieskiewicz and J. Chwiecko, Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis, J. Rheumatol. 33 (2006), 1523-1529.
32. C.R. Flannery, C.B. Little, B. Caterson and C.E. Hughes, Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes, Matrix Biol. 18 (1999), 225-237.
33. J.M. Freije, I. Diez-Itza, M. Balbin, L.M. Sanchez, R. Blasco, J. Tolivia and C. Lopez-Otin, Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas, J. Biol. Chem. 269 (1994), 16766-16773.
34. P. Germain, P. Chambon, G. Eichele, R.M. Evans, M.A. Lazar, M. Leid, A.R. De Lera, R. Lotan, D.J. Mangelsdorf and H. Gronemeyer, International union of pharmacology. LXIII. Retinoid X receptors, Pharmacol. Rev. 58 (2006), 760-772.
35. D. Ghigo, C. Priotto, D. Migliorino, D. Geromin, C. Franchino, R. Todde, C. Costamagna, G. Pescarmona and A. Bosia, Retinoic acid-induced differentiation in a human neuroblastoma cell line is associated with an increase in nitric oxide synthesis, J. Cell. Physiol. 174 (1998), 99-106.
36. J.N. Gouze, E. Gouze, M.P. Popp, M.L. Bush, E.A. Dacanay, J.D. Kay, P.P. Levings, K.R. Patel, J.P. Saran, R.S. Watson and S.C. Ghivizzani, Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta, Arthritis Res. Ther. 8 (2006), R173.
37. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok and S.R. Tannenbaum, Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids, Anal. Biochem. 126 (1982), 131-138.
38. K. Hamilton and E.W. Clair, Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis, Exp. Opin. Pharmacother. 1 (2000), 1041-1052.
39. M.B. Hansen, S.E. Nielsen and K. Berg, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, J. Immunol. Methods 119 (1989), 203-210.
40. P. Henriet, G.G. Rousseau and Y. Eeckhout, Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases, FEBS Lett. 310 (1992), 175-178.
41. K. Hirokawa, K.M. O'Shaughnessy, P. Ramrakha and M.R. Wilkins, Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids, Br. J. Pharmacol. 113 (1994), 1448-1454.
42. L.J. Ho, L.C. Lin, L.F. Hung, S.J. Wang, C.H. Lee, D.M. Chang, J.H. Lai and T.Y. Tai, Retinoic acid blocks proinflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes, Biochem. Pharmacol. 70 (2005), 200-208.
43. N. Idres, J. Marill and G.G. Chabot, Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells, Biochem. Pharmacol. 69 (2005), 1595-15601.
44. J.Y. Jouzeau, S. Pacquelet, C. Boileau, E. Nedelec, N. Presle, P. Netter and B. Terlain, Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1, Biorheology 39 (2002), 201-214.
45. M.K. Kang, Y.E. Yoon, J.Y. Yang, K.B. Kwon, J.W. Park and E.C. Jhee, Protective effect of retinoic acid on interleukin-1 beta-induced cytotoxicity of pancreatic beta-cells, Mech. Ageing Dev. 125 (2004), 483-490.
46. V. Knauper, C. Lopez-Otin, B. Smith, G. Knight and G. Murphy, Biochemical characterization of human collagenase-3, J. Biol. Chem. 271 (1996), 1544-1550.
47. C.G. Knight, F. Willenbrock and G. Murphy, A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases, FEBS Lett. 296 (1992), 263-266.
48. T. Kubota, E. Kubota, A. Matsumoto, Y. Kawai, H. Saito, Y. Mikuni-Takagaki and S. Sato, Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder, Eur. J. Oral. Sci. 106 (1998), 992-998.
49. P. Lefebvre, Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities, Curr. Drug Targets Immun. Endocr. Metabol. Disord. 1 (2001), 153-164.
50. P. Lefebvre, P.J. Martin, S. Flajollet, S. Dedieu, X. Billaut and B. Lefebvre, Transcriptional activities of retinoic acid receptors, Vitam. Horm. 70 (2005), 199-264.
51. A. Li, M. He, H. Wang, B. Qiao, P. Chen, H. Gu, M. Zhang and S. He, All-trans retinoic acid negatively regulates cytotoxic activities of nature killer cell line 92, Biochem. Biophys. Res. Commun. 352 (2007), 42-47.
52. A. Liacini, J. Sylvester, W.Q. Li and M. Zafarullah, Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappaB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes, Matrix Biol. 21 (2002), 251-262.
53. L.S. Lohmander, K.D. Brandt, S.A. Mazzuca, B.P. Katz, S. Larsson, A. Struglics and K.A. Lane, Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis, Arthritis Rheum. 52 (2005), 3160-3167.
54. S. Madhavan, M. Anghelina, B. Rath-Deschner, E. Wypasek, A. John, J. Deschner, N. Piesco and S. Agarwal, Biomechanical signals exert sustained attenuation of proinflammatory gene induction in articular chondrocytes, Osteoarthritis Cartilage 14 (2006), 1023-1032.
55. M. Mark, N.B. Ghyselinck and P. Chambon, Retinoic acid signalling in the development of branchial arches, Curr. Opin. Genet. Dev. 14 (2004), 591-518.
56. J. Martel-Pelletier, D.J. Welsch and J.P. Pelletier, Metalloproteases and inhibitors in arthritic diseases, Best Pract. Res. Clin. Rheumatol. 15 (2001), 805-829.
57. J.H. Martin, O. Alalami and F. Yaqoob, Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells, Oncol. Rep. 7 (2000), 219-223.
58. S.S. McCachren, Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium, Arthritis Rheum. 34 (1991), 1085-1093.
59. K. Mehta, T. McQueen, S. Tucker, R. Pandita and B.B. Aggarwal, Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages, J. Leukoc. Biol. 55 (1994), 336-342.
60. J.M. Milner and T.E. Cawston, Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases, Curr. Drug Targets Inflamm. Allergy 4 (2005), 363-375.
61. P.G. Mitchell, H.A. Magna, L.M. Reeves, L.L. Lopresti-Morrow, S.A. Yocum, P.J. Rosner, K.F. Geoghegan and J.E. Hambor, Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage, J. Clin. Invest. 97 (1996), 761-718.
62. M. Mohtai, R.L. Smith, D.J. Schurman, Y. Tsuji, F.M. Torti, N.I. Hutchinson, W.G. Stetler-Stevenson and G.I. Goldberg, Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1, J. Clin. Invest. 92 (1993), 179-185.
63. F. Moldovan, J.P. Pelletier, J. Hambor, J.M. Cloutier and J. Martel-Pelletier, Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta, Arthritis Rheum. 40 (1997), 1653-1661.
64. K. Motomura, M. Ohata, M. Satre and H. Tsukamoto, Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease, Am. J. Physiol. Endocrinol. Metab. 281 (2001), E420-E429.
65. K. Motomura, H. Sakai, H. Isobe and H. Nawata, Effects of retinoids on the production of tumour necrosis factor-alpha and nitric oxide by lipopolysaccharide-stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway, Cell Biochem. Funct. 15 (1997), 95-101.
66. D. Moulin, A. Bianchi, S. Boyault, S. Sebillaud, M. Koufany, M. Francois, P. Netter, J.Y. Jouzeau and B. Terlain, Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism, Arthritis Rheum. 52 (2005), 759-769.
67. A. Mukherjee, V.G. Hale, O. Borga and R. Stein, Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats, Inflamm. Res. 45 (1996), 531-540.
68. Q. Nguyen, J.S. Mort and P.J. Roughley, Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage, J. Clin. Invest. 89 (1992), 1189-1197.
69. D. Nie, Y. Ishikawa, T. Yoshimori, R.E. Wuthier and L.N. Wu, Retinoic acid treatment elevates matrix metalloproteinase-2 protein and mRNA levels in avian growth plate chondrocyte cultures, J. Cell. Biochem. 68 (1998), 90-99.
70. T. Nikawa, M. Ikemoto, K. Tokuoka, S. Teshima, D.H. Alpers, Y. Masui, K. Kishi and K. Rokutan, Interleukin-1beta enhances retinoic acid-mediated expression of bone-type alkaline phosphatase in rat IEC-6 cells, Am. J. Physiol. Gastrointest. Liver Physiol. 280 (2001), G510-G517.
71. Y. Nozaki, T. Yamagata, M. Sugiyama, S. Ikoma, K. Kinoshita and M. Funauchi, Anti-inflammatory effect of all-transretinoic acid in inflammatory arthritis, Clin. Immunol. 119 (2006), 272-279.
72. G.S. Oh, H.O. Pae, W.G. Seo, M.K. Shin, I.K. Kim, K.Y. Chai, Y.G. Yun, T.O. Kwon, J.S. Lim and H.T. Chung, Inhibitory effect of retinoic acid on expression of inducible nitric oxide synthase gene in l929 cells, Immunopharm. Immunotoxicol. 23 (2001), 335-342.
73. M. Ohata, M. Lin, M. Satre and H. Tsukamoto, Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis, Am. J. Physiol. 272 (1997), G589-G596.
74. Y. Okada, H. Nagase and E.D. Harris Jr., A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization, J. Biol. Chem. 261 (1986), 14245-14255.
75. N.J. Peake, K. Khawaja, A. Myers, D. Jones, T.E. Cawston, A.D. Rowan and H.E. Foster, Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study, Rheumatology (Oxford) 44 (2005), 1383-1389.
76. L. Raymond, S. Eck, E. Hays, I. Tomek, S. Kantor and M. Vincenti, RelA is required for IL-1beta stimulation of matrix metalloproteinase-1 expression in chondrocytes, Osteoarthritis Cartilage 15 (2007), 431-441.
77. P. Reboul, J.P. Pelletier, G. Tardif, J.M. Cloutier and J. Martel-Pelletier, The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis, J. Clin. Invest. 97 (1996), 2011-2019.
78. M.W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki and M. Rath, Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro, Med. Oncol. 23 (2006), 245-250.
79. E. Ruberte, P. Dolle, A. Krust, A. Zelent, G. Morriss-Kay and P. Chambon, Specific spatial and temporal distribution of retinoic acid receptor gamma transcripts during mouse embryogenesis, Development 108 (1990), 213-222.
80. M. Schorpp, M.G. Mattei, I. Herr, S. Gack, J. Schaper and P. Angel, Structural organization and chromosomal localization of the mouse collagenase type I gene, Biochem. J. 308(Pt 1) (1995), 211-217.
81. M. Shakibaei, T. John, G. Schulze-Tanzil, I. Lehmann and A. Mobasheri, Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis, Biochem. Pharmacol. 73 (2007), 1434-1445.
82. W.D. Shingleton, A.J. Ellis, A.D. Rowan and T.E. Cawston, Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown, J. Cell. Biochem. 79 (2000), 519-531.
83. M.A. Simonin, K. Bordji, S. Boyault, A. Bianchi, E. Gouze, P. Becuwe, M. Dauca, P. Netter and B. Terlain, PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts, Am. J. Physiol. Cell Physiol. 282 (2002), C125-C133.
84. D.R. Soprano, P. Qin and K.J. Soprano, Retinoic acid receptors and cancers, Annu. Rev. Nutr. 24 (2004), 201-221.
85. L.C. Tetlow and D.E. Woolley, Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro, Br. J. Rheumatol. 37 (1998), 64-70.
86. A. Tong, A. Reich, O. Genin, M. Pines and E. Monsonego-Ornan, Expression of chicken 75-kDa gelatinase B-like enzyme in perivascular chondrocytes suggests its role in vascularization of the growth plate, J. Bone Miner. Res. 18 (2003), 1443-1452.
87. R. Visse and H. Nagase, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry, Circ. Res. 92 (2003), 827-839.
88. Y. Wang, A.H. Moser, J.K. Shigenaga, C. Grunfeld and K.R. Feingold, Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines, J. Lipid. Res. 46 (2005), 2377-2387.
89. S.M. Wilhelm, Z.H. Shao, T.J. Housley, P.K. Seperack, A.P. Baumann, Z. Gunja-Smith and J.F. Woessner Jr., Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloprotease and effect of pH on catalytic properties and calcium affinity, J. Biol. Chem. 268 (1993), 21906-21913.
90. A.M. Wolfe, The epidemiology of rheumatoid arthritis: a review. I. Surveys, Bull. Rheum. Dis. 19 (1968), 518-523.
91. D.E. Woolley and L.C. Tetlow, Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis, Ann. Rheum. Dis. 56 (1997), 151-161.
92. P.S. Yamauchi, D. Rizk and N.J. Lowe, Retinoid therapy for psoriasis, Dermatol. Clin. 22 (2004), 467-476, x.
93. J.Y. Yang, B.S. Koo, M.K. Kang, H.W. Rho, H.S. Sohn, E.C. Jhee and J.W. Park, Retinoic acid inhibits inducible nitric oxide synthase expression in 3T3-L1 adipocytes, Exp. Mol. Med. 34 (2002), 353-360.
94. G.B. Zhou, S.J. Chen and Z. Chen, Acute promyelocytic leukemia: a model of molecular target based therapy, Hematology 10(Suppl. 1) (2005), 270-280.
95. X.F. Zhou, X.Q. Shen and L. Shemshedini, Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization, Mol. Endocrinol. 13 (1999), 276-285.
96. Y.K. Zhu, X. Liu, R.F. Ertl, T. Kohyama, F.Q. Wen, H. Wang, J.R. Spurzem, D.J. Romberger and S.I. Rennard, Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture, Am. J. Respir. Cell Mol. Biol. 25 (2001), 620-627.